Cas:1159489-46-9 1-(4-Boronophenyl)cyclopropanecarboxylic acid manufacturer & supplier

Chemical Name:1-(4-Boronophenyl)cyclopropanecarboxylic acid

CAS.NO:1159489-46-9

Synonyms:1-(4-boronophenyl)cyclopropane-1-carboxylic acid

Molecular Formula:C₁₀H₁₁BO₄

Molecular Weight:206.00300

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:77.76000

Exact Mass:206.07500

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-(4-boronophenyl)cyclopropane-1-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(4-boronophenyl)cyclopropane-1-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(4-boronophenyl)cyclopropane-1-carboxylic acid Use and application,1-(4-boronophenyl)cyclopropane-1-carboxylic acid technical grade,usp/ep/jp grade.

Related News: Common signs of infection include respiratory symptoms, fever, cough, shortness of breath and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death. 1-(4-Boronophenyl)cyclopropanecarboxylic acid manufacturer The company��s iPSC product platform unites stem cell biology and precision genetic engineering to create renewable master engineered iPSC lines that can be repeatedly used to mass produce cancer-fighting immune cells, replacing the high production costs, weeks of manufacturing time, and complex engineering processes required for current-generation CAR T-cell immunotherapies with an off-the-shelf product that has the potential to reach many more patients. 1-(4-Boronophenyl)cyclopropanecarboxylic acid supplier Common signs of infection include respiratory symptoms, fever, cough, shortness of breath and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death. 1-(4-Boronophenyl)cyclopropanecarboxylic acid vendor Australia has started denying entry to all travelers who have come from or transited through mainland China. 1-(4-Boronophenyl)cyclopropanecarboxylic acid factory Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,�� Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.